Pharma stocks upbeat amid Covid-19 scare; Divi's, Lupin can gain up to 10%

Technically, the Nifty Pharma index needs to immediate hurdle at 13,500, for further upside to 14,250.

Stock markets across the globe this traded on a jittery note amid reports of fresh spike in COVID-19 cases across China, and also cities in the US, Europe and Japan. The Indian markets slipped over 2 per cent in the previous two trading sessions and have plunged 4.7 per cent from the all-time high recorded at the start of this December. 

Even as the US benchmarks, Dow Jones and Nasdaq trade in green for the current week, both the indices were 4 per cent lower from their recent 3-week highs. Similarly, FTSE in UK, DAX in Germany and CAX in